Related Experiment Video
Updated: Jul 10, 2026

06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Magnetic Resonance Imaging-based Prostate Cancer Diagnosis Using Principal Component Analysis and Machine Learning
N Samta1, C S Sureka1, Sivananthan Sarasanandarajah2
1Department of Medical Physics, Bharathiar University, Coimbatore, Tamil Nadu, India.
Journal of Medical Physics
|July 9, 2026
Summary
Principal component analysis (PCA) combined with machine learning (ML) effectively distinguishes prostate cancer from benign lesions in MRI scans. This PCA-ML approach improves diagnostic accuracy for early prostate cancer detection.
Area of Science:
- Medical Imaging
- Machine Learning
- Oncology
Background:
- Prostate cancer poses a significant threat to men's health, underscoring the need for precise diagnostic tools.
- Accurate differentiation between benign and malignant prostate lesions is crucial for effective treatment planning.
Purpose of the Study:
- To assess the efficacy of principal component analysis (PCA) integrated with machine learning (ML) for classifying prostate lesions using MRI.
- To compare the performance of PCA-transformed features against raw pixel and radiomics features for lesion classification.
Main Methods:
- Magnetic resonance imaging (MRI) data from 26 prostate cancer patients were analyzed.
- Principal component analysis (PCA) was employed for feature extraction from MRI images.
- Random Forest, SVM, and KNN classifiers were utilized to categorize lesions based on extracted features.
Main Results:
- PCA-based features showed significant separation between benign and malignant tissues (P < 2.2 × 10⁻¹⁶).
- The Random Forest classifier achieved the highest diagnostic performance with an AUC of 0.909.
- PCA-enhanced models outperformed raw pixel-based methods, with radiomics features providing further improvements.
Conclusions:
- PCA-based feature extraction enhances classification accuracy by reducing noise and dimensionality in MRI data.
- The proposed PCA-ML framework provides an interpretable and efficient method for prostate cancer diagnosis.
- This approach offers a clinically valuable tool for early and accurate detection of prostate cancer.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

